EP Patent

EP0251476A1 — Controlled release of macromolecular polypeptides

Assigned to Syntex USA LLC · Expires 1988-01-07 · 38y expired

What this patent protects

An active agent delivery system for the controlled administration of macromolecular polypeptides which comprises a micro-suspension of water-soluble components in a polylactide matrix.

USPTO Abstract

An active agent delivery system for the controlled administration of macromolecular polypeptides which comprises a micro-suspension of water-soluble components in a polylactide matrix.

Drugs covered by this patent

Patent Metadata

Patent number
EP0251476A1
Jurisdiction
EP
Classification
—
Expires
1988-01-07
Drug substance claim
No
Drug product claim
No
Assignee
Syntex USA LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.